期刊文献+

比拉斯汀重要中间体的合成

Synthesis of the Key Intermediate of Bilastine
原文传递
导出
摘要 1-Boc-4-哌啶甲醇发生氧化反应得1-Boc-哌啶-4-甲醛,与2-硝基苯胺发生还原-闭环反应得4-(1H-苯并[d]咪唑-2-基)哌啶-1-羧酸叔丁酯,与2-氯乙基乙醚发生烷基化反应,再经水解得合成比拉斯汀的重要中间体1-(2-乙氧基-乙基)-2-哌啶-4-基-1H-苯并咪唑,总收率约73%。 1-Boc-piperidine-4-carboxaldehyde was prepared from 1-Boc-4-piperidinemethanol via oxidation, then it reacted with 2-nitroaniline to afford tert-butyl 4-(1H-benzimidazol-2-yl)piperidine-l-carboxylate by reductioncyclization, the latter reacted with 2-chloroethyl ethyl ether followed by hydrolysis to give the key intermediate of bilastine, 1- (2-ethoxyethyl) -2-piperidin-4-yl-benzimidazole, with a total yield of about 73 %.
作者 赵军
机构地区 兰陵县人民医院
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2016年第11期1363-1365,共3页 Chinese Journal of Pharmaceuticals
关键词 比拉斯汀 中间体 合成 bilastine intermediate synthesis
  • 相关文献

参考文献10

  • 1Corc6stegui R, Labeaga L, Inner_hrity A, et al. Preclinical pharmacology of bilastine, a new selective histamine H receptor antagonist: receptor selectivity and in vitro anti- histaminic activity [J]. Drugs R D, 2005, 6 (6) : 371--384.
  • 2Carter NJ. Bilastine: in allergic rhinitis and urticaria [J]. Drugs, 2012, 72(9): 1257--1269.
  • 3Sadaba B, Azanza JR, Gomez-Guiu A, et al. Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria [J]. Ther Clin Risk Manag, 2013, 9(4) : 197--205.
  • 4梅开忠,黄欣.比拉斯汀化合物及其制备方法:中国,104530002[P].2015-04.22.
  • 5Orjales A, Rubio V, Bordell M. Benzimidazole derivatives with antihistaminic activity: EP, 0818454 [P]. 1998-01-14.
  • 6Orjales-Venero A, Rubio-Royo V. New piperidine derivatives of benzimidazole as antihistaminic and antiaUergic agents: EP, 0580541 [P]. 1994-01-26.
  • 7Collier SJ, Wu X, Poh Z, et al. Alternative synthesis of bilastine [J]. Synth Commun, 2011, 41 (9): 1394--1402.
  • 8王蕾,李科,王倩,等.2-(4-卤乙基)苯基.2.甲基丙酸酯的制备方法及合成比拉斯汀的方法:中国,102675101[P].2012-09-19.
  • 9孔昊,耿海明,梅玉丹,朱晓琦,孙平华.比拉斯汀的合成[J].中国医药工业杂志,2015,46(7):677-679. 被引量:2
  • 10Lee CH, Khoo JH, Kwon KC, et al. Process for preparation of 2-methyl-2'-phenylpropionic acid derivatives and novel intermediate compounds: WO, 2009102155 [P]. 2009-08-20.

二级参考文献9

  • 1Corc6stegui R, Labeaga L, Innerrity A, et al. Preclinical pharmacology of bilastine, a new selective histamine Hl receptor antagonist: receptor selectivity and in vitro anti- histaminic activity [J]. Drugs R D, 2005, 6 (6) : 371-384.
  • 2Carter NJ. Bilastine: in allergic rhinitis and urticaria [J]. Drugs, 2012, 72(9): 1257-1269.
  • 3Sadaba B, Azanza JR, Rodil R, et al. Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria [J]. Ther Clin RiskManag, 2013, 9: 197-205.
  • 4Orjales A, Rubio V, Bordell M. Benzimidazole derivatives with antihistaminic activity: EP, 0818454 [P]. 1998-01-14.
  • 5Orjales-Venero A, Rubio-Royo V. New piperidine derivatives of benzimidazole as antihistaminic and antiallergic agents: EP, 0580541 [P]. 1994-01-26.
  • 6Collier S J, Wu X, Poh Z, et al. Alternative synthesis of bilastine [J]. Synth Commun, 2011, 41 (9) : 1394-1402.
  • 7Lee CH, Khoo JH, Kwon KC, et al. Process for preparation of 2-methyl-2-phenylpropionic acid derivatives and novel intermediate compounds: WO, 2009102155 [P]. 2009-02-12.
  • 8王蕾,李科,王倩,等.2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法:中国.102675101[P].2012-09-19.
  • 9Matsumoto N, Kohno T, Uchida S, et al. Preparation of antibodies against a novel immunosuppressant FTY720, and development of an enzyme immunoassay for FTY720 [J]. Bioorg Med Chem, 2006, 14 (12) : 4182-4192.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部